Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Religare Enterprises to classify promoters as public shareholders

      Religare Enterprises to classify promoters as public shareholders

      Ruby Khatun Khatun13 Aug 2018 10:45 AM IST
      New Delhi: Financial services conglomerate Religare Enterprise said the promoter and promoter groups of the company will be reclassified into a public...
      Hetero pulls heart drug from US amid cancer risk probes

      Hetero pulls heart drug from US amid cancer risk probes

      Ruby Khatun Khatun13 Aug 2018 10:30 AM IST
      MUMBAI: A unit of Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S....
      AIIA signs MoU with IIT to boost research in traditional medicine

      AIIA signs MoU with IIT to boost research in traditional medicine

      Ruby Khatun Khatun13 Aug 2018 10:15 AM IST
      New Delhi: A premier institute of Ayurveda under the AYUSH Ministry signed a MoU with the Indian Institute of Technology here to boost research in...
      FDA approves first generic drug under new pathway

      FDA approves first generic drug under new pathway

      Ruby Khatun Khatun13 Aug 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) approved several strengths of the potassium chloride oral solution as the first generic drugs to receive a...
      AstraZeneca settles Texas drug lawsuits for 110 million dollar

      AstraZeneca settles Texas drug lawsuits for 110 million dollar

      Ruby Khatun Khatun13 Aug 2018 9:45 AM IST
      LONDON: Drugmaker AstraZeneca has agreed to pay $110 million to settle two lawsuits brought by the state of Texas claiming that it fraudulently...
      Novo Nordisk sales disappoint, sees lower 2019 US prices

      Novo Nordisk sales disappoint, sees lower 2019 US prices

      Ruby Khatun Khatun13 Aug 2018 9:30 AM IST
      COPENHAGEN: Shares in Novo Nordisk fell after sales of some of its key drugs in the second quarter fell short of expectations and it said prices in...
      9 arrested for manufacturing spurious drug

      9 arrested for manufacturing spurious drug

      Ruby Khatun Khatun12 Aug 2018 11:00 AM IST
      Agartala: Nine people were held for manufacturing spurious drugs and they were sent to the five days police custody for further investigation by the...
      Cipla secures marketing rights for cancer drug in US

      Cipla secures marketing rights for cancer drug in US

      Ruby Khatun Khatun12 Aug 2018 10:45 AM IST
      New Delhi: Drug major Cipla said its subsidiary has secured rights from Hyderabad-based MSN Laboratories to market and distribute colon cancer...
      FDA approves Galafold for a rare genetic disorder, Fabry disease

      FDA approves Galafold for a rare genetic disorder, Fabry disease

      Ruby Khatun Khatun12 Aug 2018 10:45 AM IST
      New Delhi: The U.S. Food and Drug Administration (FDA) approved Galafold (migalastat), the first oral medication for the treatment of adults with...
      732 complaints of misleading advertisements regarding herbal medicines: Minister informs Parliament

      732 complaints of misleading advertisements regarding herbal medicines: Minister informs Parliament

      Ruby Khatun Khatun12 Aug 2018 10:15 AM IST
      New Delhi: The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in a written reply to a question in Rajya Sabha 732...
      Aditya Birla Health Insurance ties with SVC Bank as bancassurance channel

      Aditya Birla Health Insurance ties with SVC Bank as bancassurance channel

      Ruby Khatun Khatun12 Aug 2018 10:00 AM IST
      New Delhi: Aditya Birla Health Insurance Co has tied-up with urban co-operative lender SVC Bank as a corporate agency partner to sell its policies...
      WISH Foundation to add 100 health and wellness centres in India by October

      WISH Foundation to add 100 health and wellness centres in India by October

      Ruby Khatun Khatun12 Aug 2018 9:45 AM IST
      New Delhi: Wadhwani Initiative for Sustainable Healthcare (WISH Foundation), set up by IGate Co-founder Sunil Wadhwani, is planning to add 100...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok